Cell, tissue and gene therapies – Regulatory challenges and responses in Australia | Hogan Lovells

Australian regulation of cell, tissue, and gene therapies (CTGT) is relatively new, with the regulatory framework for biological medical products first being introduced in 2011. A...

Related Keywords

Australia ,Australian , ,National One Stop Shop ,Office Of The Gene Technology Regulator ,Advisory Committee ,Tissue Regulatory Framework ,Stakeholder Perspective ,Clinical Trial Approval ,Clinical Trial Notification ,Gene Technology Regulator ,Pharmaceutical Benefits Advisory Committee ,Australian Register ,Therapeutic Goods ,Therapeutic Goods Regulations ,Therapeutic Goods Act ,Digital Transformation Project ,